Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001544569 | SCV001763725 | likely benign | not provided | 2020-02-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002071979 | SCV002409159 | benign | Neurofibromatosis, type 1 | 2024-08-28 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002071979 | SCV002561340 | benign | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002495868 | SCV002795791 | likely benign | Neurofibromatosis, familial spinal; Juvenile myelomonocytic leukemia; Neurofibromatosis, type 1; Neurofibromatosis-Noonan syndrome; Café-au-lait macules with pulmonary stenosis | 2022-01-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004550314 | SCV004749947 | likely benign | NF1-related disorder | 2020-09-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |